Security
CM Life Sciences III Inc. Unit · CMLTU
CMLTUNASDAQUnitHistorical · closed Dec 17, 2021CIK 1843762Updated Oct 6, 2026
Name history
CM Life Sciences III Inc. · through Dec 17, 2021
CMLTU price & chart
Historical security
This listing closed Dec 17, 2021. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2023 | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| AssetsUSD | 1,240,290,000Source | 1,543,413,000Source | 554,188,289Source | 1,311,398,000Source | 1,608,279,000Source | 553,337,784Source | 1,383,955,000Source | 1,674,120,000Source | 1,455,016,000Source | 1,729,442,000Source | 500,528,000Source |
| Property, Plant and Equipment, NetUSD | — | 1,794,000Source | — | 2,316,000Source | 1,516,000Source | — | 2,590,000Source | 1,611,000Source | 2,627,000Source | 1,985,000Source | 2,720,000Source |
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 315,676,000Source | 998,022,000Source | 456,470,000Source | 247,500,000Source | 864,436,000Source | 500,158,000Source | 368,358,000Source | 1,623,268,000Source | 494,136,000Source | 1,678,542,000Source | 489,682,000Source |
| Assets, CurrentUSD | 1,235,139,000Source | 1,523,990,000Source | 2,172,856Source | 1,284,341,000Source | 1,588,291,000Source | 1,330,325Source | 1,354,978,000Source | 1,655,260,000Source | 1,428,086,000Source | 1,706,202,000Source | 492,276,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 22,206,000Source | 24,642,000Source | — | 22,785,000Source | 30,944,000Source | — | 29,036,000Source | 31,992,000Source | 28,800,000Source | 27,660,000Source | 2,594,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | 4,355,000Source | — | 2,660,000Source | 4,889,000Source | — | 3,238,000Source | 2,084,000Source | 3,804,000Source | 2,672,000Source | 4,863,000Source |
| Other Assets, NoncurrentUSD | 1,151,000Source | 8,641,000Source | — | 17,448,000Source | 8,950,000Source | — | 18,516,000Source | 10,532,000Source | 15,866,000Source | 13,950,000Source | 36,000Source |
| LIABILITIES AND EQUITY | |||||||||||
| LiabilitiesUSD | 69,370,000Source | 143,451,000Source | 74,361,443Source | 63,080,000Source | 133,778,000Source | 81,123,261Source | 69,644,000Source | 125,543,000Source | 66,154,000Source | 214,603,000Source | 18,446,000Source |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, IssuedUSD | 49,000Source | 49,000Source | — | 49,000Source | 49,000Source | 848Source | 49,000Source | 49,000Source | 49,000Source | 49,000Source | 31,000Source |
| Additional Paid in CapitalUSD | 1,936,346,000Source | 1,906,947,000Source | — | 1,931,231,000Source | 1,896,797,000Source | 36,838,090Source | 1,924,318,000Source | 1,886,294,000Source | 1,916,550,000Source | 1,873,289,000Source | 740,542,000Source |
| Retained Earnings (Accumulated Deficit)USD | -765,727,000Source | -505,412,000Source | -72,174,534Source | -683,096,000Source | -420,320,000Source | -31,840,315Source | -610,140,000Source | -337,774,000Source | -527,589,000Source | -358,500,000Source | -258,491,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 252,000Source | -1,622,000Source | — | 134,000Source | -2,025,000Source | — | 84,000Source | 8,000Source | -148,000Source | 1,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 1,170,920,000Source | 1,399,962,000Source | -72,173,154Source | 1,248,318,000Source | 1,474,501,000Source | 5,000,003Source | 1,314,311,000Source | 1,548,577,000Source | 1,388,862,000Source | 1,514,839,000Source | 482,082,000Source |
| Liabilities and EquityUSD | 1,240,290,000Source | 1,543,413,000Source | 554,188,289Source | 1,311,398,000Source | 1,608,279,000Source | 553,337,784Source | 1,383,955,000Source | 1,674,120,000Source | 1,455,016,000Source | 1,729,442,000Source | 500,528,000Source |
| Current liabilities: | |||||||||||
| Liabilities, CurrentUSD | 65,786,000Source | 62,659,000Source | 2,119,311Source | 56,824,000Source | 55,255,000Source | 198,462Source | 59,884,000Source | 56,637,000Source | 51,916,000Source | 39,646,000Source | 14,196,000Source |
| Operating Lease, Liability, CurrentUSD | 2,060,000Source | 2,496,000Source | — | 2,430,000Source | 2,619,000Source | — | 2,368,000Source | 2,629,000Source | 2,370,000Source | 3,102,000Source | 1,712,000Source |
| Accounts Payable, CurrentUSD | 8,103,000Source | 14,063,000Source | 21,251Source | 6,586,000Source | 13,019,000Source | 44,029Source | 20,731,000Source | 7,323,000Source | 19,950,000Source | 7,640,000Source | 1,319,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 2,060,000Source | — | 215,000Source | 2,645,000Source | — | 849,000Source | — | 1,461,000Source | 272,000Source | 3,373,000Source |
| Additional Financial Items | |||||||||||
| Accrued Liabilities, CurrentUSD | 55,623,000Source | 46,100,000Source | 1,963,764Source | 47,808,000Source | 39,617,000Source | 70,000Source | 36,785,000Source | 46,685,000Source | 29,596,000Source | 28,904,000Source | 11,165,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 1,200,000,000Source | 1,500,000,000Source | — | 1,300,000,000Source | 1,600,000,000Source | — | 1,300,000,000Source | — | 1,400,000,000Source | — | — |
| Short-term InvestmentsUSD | 896,624,000Source | 501,326,000Source | — | 1,014,056,000Source | 692,911,000Source | — | 957,584,000Source | — | 905,150,000Source | — | — |
cash flow · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -82,551,000Source | 20,726,000Source | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 188,000Source | 410,000Source | 935,000Source | 1,183,000Source | 338,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 7,592,000Source | 12,906,000Source | 41,551,000Source | 26,226,000Source | 346,000Source |
| Changes in operating assets and liabilities: | |||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 1,074,000Source | -162,000Source | 12,044,000Source | 6,143,000Source | 324,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -85,546,000Source | -53,938,000Source | -287,268,000Source | -183,180,000Source | -241,506,000Source |
| Cash flows from investing activities: | |||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -40,359,000Source | -13,000Source | -897,277,000Source | -4,448,000Source | -2,980,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 444,000Source | 13,000Source | 1,133,000Source | 448,000Source | 2,980,000Source |
| Cash flows from financing activities: | |||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 127,000Source | -1,323,000Source | 139,000Source | 1,376,488,000Source | 715,479,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -125,778,000Source | -55,274,000Source | -1,184,406,000Source | 1,188,860,000Source | 470,993,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 316,309,000Source | 998,655,000Source | 248,133,000Source | 865,069,000Source | 368,991,000Source | 1,623,901,000Source | 494,769,000Source | 1,679,175,000Source | 490,315,000Source |
| Additional Financial Items | |||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 4,869,000Source | 9,432,000Source | 6,790,000Source | 9,988,000Source | 7,592,000Source | 12,906,000Source | 41,551,000Source | 26,226,000Source | 346,000Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 1,200,000,000Source | 1,500,000,000Source | 1,300,000,000Source | 1,600,000,000Source | 1,300,000,000Source | — | 1,400,000,000Source | — | — |
| DepreciationUSD | — | — | — | 200,000Source | — | 200,000Source | — | 400,000Source | — | 1,200,000Source | 300,000Source |
| General and Administrative ExpenseUSD | — | — | 23,404,000Source | 34,095,000Source | 21,476,000Source | 31,792,000Source | 27,277,000Source | 32,263,000Source | 127,382,000Source | 78,266,000Source | 25,689,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -82,631,000Source | -85,092,000Source | -72,956,000Source | -82,546,000Source | -82,551,000Source | 20,726,000Source | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -82,631,000Source | -85,092,000Source | -72,956,000Source | -82,546,000Source | -82,551,000Source | 20,034,000Source | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Nonoperating Income (Expense)USD | — | — | 18,917,000Source | 5,274,000Source | 18,880,000Source | -3,456,000Source | 19,247,000Source | 106,417,000Source | 186,788,000Source | 96,366,000Source | 97,000Source |
| Operating ExpensesUSD | — | — | 101,548,000Source | 90,366,000Source | 91,836,000Source | 79,090,000Source | 101,798,000Source | 85,691,000Source | 355,877,000Source | 196,375,000Source | 250,080,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | 481,000Source | 222,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 12,000Source | -32,000Source | -8,000Source | -526,000Source | -12,000Source | 514,000Source | -65,000Source | -15,000Source | — |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 628,525,000Source | — | 1,406,097,000Source | 4,000,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | 40,000Source | — | 668,000Source | 945,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 127,000Source | 40,000Source | 1,502,000Source | — | — |
| Realized Investment Gains (Losses)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source | — | — |
income statement · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income (Loss)USD | — | — | -101,548,000Source | -90,366,000Source | -91,836,000Source | -79,090,000Source | -101,798,000Source | -85,691,000Source | -355,877,000Source | -196,375,000Source | -250,080,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 12,000Source | -32,000Source | -8,000Source | -526,000Source | -12,000Source | 514,000Source | -65,000Source | -15,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -82,631,000Source | -85,092,000Source | -72,956,000Source | -82,546,000Source | -82,551,000Source | 20,726,000Source | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.17Source | -0.18Source | -0.15Source | -0.17Source | -0.17Source | 0.04Source | -0.36Source | -0.31Source | -1.81Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.17Source | -0.18Source | -0.15Source | -0.17Source | -0.17Source | 0.04Source | -0.36Source | -0.31Source | -1.81Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 484,229,709Source | 475,565,990Source | 482,119,498Source | 473,058,458Source | 480,010,594Source | 470,627,083Source | 474,295,855Source | 324,008,969Source | 137,824,126Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 484,229,709Source | 475,565,990Source | 482,119,498Source | 473,058,458Source | 480,010,594Source | 491,792,152Source | 474,295,855Source | 324,008,969Source | 137,824,126Source |
| Additional Financial Items | |||||||||||
| General and Administrative ExpenseUSD | — | — | 23,404,000Source | 34,095,000Source | 21,476,000Source | 31,792,000Source | 27,277,000Source | 32,263,000Source | 127,382,000Source | 78,266,000Source | 25,689,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -169,069,000Source | -100,076,000Source | -249,983,000Source |
| Interest Income, OtherUSD | — | — | 16,485,000Source | 8,209,000Source | 16,068,000Source | 4,091,000Source | 15,442,000Source | 182,000Source | 25,150,000Source | 436,000Source | 97,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -82,631,000Source | -85,092,000Source | -72,956,000Source | -82,546,000Source | -82,551,000Source | 20,034,000Source | -169,089,000Source | -100,009,000Source | -249,983,000Source |
| Nonoperating Income (Expense)USD | — | — | 18,917,000Source | 5,274,000Source | 18,880,000Source | -3,456,000Source | 19,247,000Source | 106,417,000Source | 186,788,000Source | 96,366,000Source | 97,000Source |
| Operating ExpensesUSD | — | — | 101,548,000Source | 90,366,000Source | 91,836,000Source | 79,090,000Source | 101,798,000Source | 85,691,000Source | 355,877,000Source | 196,375,000Source | 250,080,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | 481,000Source | 222,000Source |
| Realized Investment Gains (Losses)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | — | 0Source | — | — |
| Research and Development ExpenseUSD | — | — | 19,729,000Source | 56,271,000Source | 43,574,000Source | 47,298,000Source | 70,933,000Source | 53,428,000Source | 228,495,000Source | 118,109,000Source | 224,391,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | — | — | — | — | — | — | —Source | — | — | — |